Ypsomed Holding AG (YPSN.SW)

Swiss · Healthcare · Medical Instruments & Supplies
434.40 CHF-1.41%As of 2026-11-22 · CHF
Last session low 430.80 CHFLast session high 440.80 CHF
52-week low 260.50 CHF52-week high 447.80 CHF
Market cap (USD)
$6.80B
Sector
Healthcare
P/E (TTM)
34.4x
Dividend yield
1.01%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CHF.

IndicatorValueReading
RSI (14)64.6In the neutral range (30 to 70)
MACD (12, 26, 9)15.39Above its signal line (12.45); histogram 2.94
Bollinger %B (20, 2)82%Inside the bands (370.52 to 447.96)
SMA 20409.24Price is 6.1% above
SMA 50382.28Price is 13.6% above
SMA 200346.15Price is 25.5% above
ATR (20)2.53% of priceAverage true range per day
52-week position93%In the upper part of the 260.50 to 447.80 range

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services.

Latest fiscal yearEnded 2026-03-31: revenue of 730.98M CHF and an operating margin of 33.7%.

More in Medical Instruments & Supplies